乳腺专科项目
申请报告/方案汇报
乳腺科
为进一步提升我院乳腺疾病的诊疗水平，满足广大女性患者的健康需求，经过充分调研和论证，现向医院申请成立乳腺专科。
- 项目背景
333下辖2个街道、10个镇、1个乡，333户籍人口总数约为66.8万人。辖区内有333第一人民医院、第二人民医院、中医院等众多医疗机构。333城距泰山56公里。
为了保持我院在医疗领域的领先地位需要不断发展和建立新专科；引入和掌握成熟技术和学科体系，为患者提供更加精准、有效的治疗；扩大我院的服务范围，提升服务能力，方能提高竞争力和拓展发展空间，发挥妇幼保健院要围绕妇女和儿童的健康发展的功能定位。
- 乳腺疾病诊疗领域现状及333乳腺疾病患者现状
据国家癌症中心发布的《中国乳腺癌现状报告》，全球每确诊100例乳腺癌，有12名来自中国；新发病率增长速度是全球平均水平的2倍，平均发病年龄比西方国家早10-15年；《中国女性乳腺癌筛查与早诊早治指南（2021.北京）》首次明确：乳腺良性疾病位居乳腺癌发病风险因素首位。
综合各权威资料的数据测算，我国女性乳腺良性疾病患者数量庞大，约占各地常住人口总数的10%！按照大样本统计，333人口中的乳腺病患者有8万人以上。
- 发展乳腺专业学科是我院新的发展机遇
1.政策支持：
《关于坚持以人民健康为中心推动医疗服务高质量发展的意见》国家卫生健康委员会高度重视妇女健康，要加强基层公立医院能力建设，提升核心专科、夯实支撑专科、打造优势专科，提高肿瘤等疾病的防治能力；鼓励医疗机构加强乳腺疾病的早期筛查和规范化治疗。
2.发展机遇
目前333乃至333市各级综合医院仍以乳腺肿瘤手术为主要诊疗手段。这种现象对我院与各大型医院展开错位竞争、落实分级诊疗，实现特色专科弯道超车提供了绝佳发展机遇！
四、乳腺学科建设能够解决的问题
1.病患来源问题：没有足够的病源，医疗专业学科难以立足，更难以发展。由于历史的原因，我院乳腺专业初有雏形，缺乏品牌影响力，导致乳腺病就诊量少，医疗服务量不足。必须采取有效的措施吸引乳腺病患者到院就医，才能保证诊疗业务有效开展。
- 病患留治问题：即使有效的宣传推广运营吸引到病患来院就医，但如果接诊医生能力不足难以留住患者；沟通不当使患者不信任，解释不到位让患者质疑甚至可能留下医疗纠纷隐患，最终患者还是放弃我院而到其他医院。所以，掌握诊断技术做到诊断准确，有效沟通使患者信任，解释病情清晰使患者对疾病正确认识，从而愿意接受医疗服务以保证有效服务量。
3.乳腺专科的成立将填补我院在该领域的空白，能够增强我院的综合实力和区域影响力。乳腺专科的成立有助于推动我院相关学科（如妇科、产科、外科、影像科）的协同发展，提升整体医疗水平。
五、乳腺科发展方向
建设一个多学科协作、多专业融合的新型专业学科，发挥综合技术优势，提高市场竞争力和综合服务能力。
开展乳腺疾病全病种治疗：包括非肿瘤性性疾病的中西医结合治疗和良性肿瘤的微创治疗；乳房保健：包括青春期乳房促进发育与畸形发育的矫治、围哺乳期促进泌乳保健、哺乳期促进母乳喂养、断乳期预防疾病及乳房变形保健等；肿瘤康复管理：包括妇科肿瘤及乳腺癌术后功能恢复与康复管理、负面心理矫治、中医体质调理、膳食营养管理、放化疗副作用矫治、肿瘤患者群体社会融入管理等。
六、综合效益分析：
在设备配置合理，技术基本掌握，宣传能够到位的前提下，可达到以下综合效益。
1.门诊检查收入
采用有效综合营销策划方案，提高彩超检查率80%、X线检查率30%、乳管镜检查率10%。
凡需做乳管镜检查者均需做相关传染病及血常规和凝血机制检查，检验费收入。
2.良性非肿瘤疾病治疗收入
采用规范检查，非肿瘤性疾病阳性检出率50%，每月检出阳性患者495例，其中轻症患者约占70%，愿意进行门诊治疗的患者占50%，根据病情不同治疗费用在3000-5000元/人之间；
3.乳腺外科微创或开放手术治疗收入：良性肿瘤患者占门诊人数的2% ~ 3%；
4.产后哺乳障碍治疗收入：治疗产后积乳、缺乳患者的治疗；
5.乳腺癌康复管理：国家明确规定对癌症患者实施慢病管理，每例患者每年综合医疗费用以1.5万计算，收治乳腺癌术后康复患者增加医疗效益。
七、建设模式
采用借力助力的方式，邀请有成功建设学科经验的专业团队，从学科筹建、体系构建、人才培养、技术培训、运营管理等方面进行全方位指导，从而打造功能齐全、结构完善、有效医疗、效益显著的专业学科体系。
八、乳腺专科建设项目配套设备
| 序号 | 产品名称 | 数量 | 功能 |
| 1 | 乳腺导管内窥镜
（检查治疗设备） |
1 | （1）解决了乳管内病变只能间接诊断而不能直观的难题，为乳管内病变的定性开辟了一个新的诊断途径。对早期肿瘤的患者可以及时发现、治疗。
(2)瘤体定位问题：使需要手术的绝大部分患者，缩小了手术范围修改了乳腺疾病部分手术指征，使部分患者避免不必要的手术。 |
| 2 | 乳腺治疗仪
（治疗设备） |
3 | （1）其治疗功效主要是采取仿生按摩与仿真推拿针灸，施治于乳腺病变部位，消除组织粘连，通过经⽪神经电刺激（TENS），消除疼痛。
（2）乳腺治疗仪在临床治疗体系内的另一大作用功能是配合进行“乳腺导管介入灌洗治疗”，是实现疗效的基础设备。80%以上的乳腺原位癌发源于乳导管，诸多良性疾病更是与乳导管的淤堵有直接关联。 |
| 3 | 乳腺中药汽化治疗机
（治疗设备） |
3 | （1）中药汽化后，有效成份以微粒子形式存在，能够更有效透过皮肤而进入乳房组织内。
(2)与药物汽化治疗同步进行，使治疗效果明显提高。根据现代医学诊断和传统医学辨证分型，配合专家多年经验中药配方，针对性更强，治疗效果更好。专用于乳房部位治疗，可与后续治疗无缝衔接； |
| 4 | 病源管理系统
（引流及推广） |
1 | （1） 信息化系统内含乳腺疾病咨询信息知识库管理，预约知识库、疾病知识库、患者知识库、专家知识库管理； （2）信息化系统可实现门诊科室预约、门诊医生预约、治疗预约、初复诊预约管理；日程安排管理，信息化系统可完成患者分类和级别管理，按患者不同分类筛选跟踪服务；系统自动提示回访随访，实现患者回访与联系的自动化管理，随访管理子系统可定制随访条件：如预约、复查、疾病种类、患者属性、患者生日、患者来源、患者等级，并依据随访范围定制随访内容，批量群发短信或微信； （3）系统包含投诉管理，投诉管理，对患者投诉情况进行登记分类； （4）系统自动进行媒体推广分析：广告效果分析、区域患者分析，营销方式分析； |
| 5 | 乳腺科体系建设及技术培训 | ||
以上报告如无不妥，请医院领导审核批准立项。
Breast Specialty Project
Application Report / Proposal Brief
Department of Breast Diseases
To further enhance our hospital’s diagnostic and treatment capabilities for breast diseases and to meet the growing health needs of female patients, and after comprehensive research and evaluation, we hereby request the establishment of a specialized breast department.
Project Background
The 333 region governs 2 subdistricts, 10 towns, and 1 township, with a total registered population of approximately 668,000. Within its jurisdiction are numerous medical institutions—including the 333 First People’s Hospital, Second People’s Hospital, and a Traditional Chinese Medicine Hospital. The urban center of 333 is located 56 kilometers from Mount Tai.
In order to maintain our hospital’s leading position in the healthcare field, it is essential to continuously develop and establish new specialties; to introduce and master mature technologies and disciplinary frameworks for providing more precise and effective treatments; and to expand our service range and capacity—thus enhancing our competitiveness and growth potential. This aligns with the core mission of a maternal and child health institution focused on women’s and children’s well-being.
Current Status of Breast Disease Diagnosis and Patient Demographics in 333
According to the “China Breast Cancer Status Report” released by the National Cancer Center, out of every 100 diagnosed cases of breast cancer worldwide, 12 are from China; the incidence rate is growing at twice the global average, and the average age of onset is 10–15 years earlier than in Western countries. Furthermore, the “Guidelines for Breast Cancer Screening, Early Diagnosis and Early Treatment for Chinese Women (2021, Beijing)” have, for the first time, clearly identified benign breast diseases as the primary risk factor for breast cancer.
Based on data from various authoritative sources, the number of women with benign breast diseases in our country is enormous—approximately 10% of the local resident population. According to large-scale statistical studies, there are over 80,000 breast disease patients in the 333 area.
Developing a specialized breast discipline presents a new opportunity for our hospital’s growth:
-
Policy Support
The “Opinions on Adhering to a People-Centered Approach to Promote High-Quality Development of Medical Services” emphasizes that the National Health Commission places great importance on women’s health. The document calls for strengthening the capacity of grassroots public hospitals, enhancing core specialties, consolidating supporting specialties, and developing areas of competitive advantage to improve the prevention and treatment of tumors and other diseases. It also encourages medical institutions to promote early screening and standardized treatment of breast diseases. -
Development Opportunities
Currently, comprehensive hospitals at various levels in the 333 region—and even in 333 City—primarily rely on breast tumor surgery as their main diagnostic and treatment method. This situation provides our hospital with an excellent opportunity to engage in differentiated competition with larger hospitals, implement hierarchical diagnosis and treatment, and achieve a leap forward by developing a specialized department with unique features.
IV. Issues Addressed by Establishing the Breast Discipline
-
Patient Source Challenges
Without a sufficient patient base, a medical specialty cannot be sustained or developed. Historically, our hospital’s breast specialty has only taken its initial shape and lacks strong brand influence, resulting in a low volume of breast disease consultations and inadequate service delivery. Effective measures must be adopted to attract breast disease patients to our facility to ensure that diagnostic and treatment services operate efficiently. -
Patient Retention Challenges
Even if effective promotional efforts succeed in drawing patients, inadequate clinical expertise may result in losing them. Poor communication can erode patient trust, and insufficient explanations can lead to doubts or even potential risks of medical disputes, ultimately causing patients to seek treatment elsewhere. Therefore, mastering diagnostic techniques for accurate assessments, communicating effectively to build trust, and providing clear explanations to help patients understand their conditions are essential for ensuring a stable flow of patients. -
Overall Impact
Establishing a specialized breast department will fill an existing gap in our hospital, enhancing both our overall strength and regional influence. It will also promote the coordinated development of related disciplines—such as gynecology, obstetrics, surgery, and radiology—thereby raising our overall level of medical care.
V. Development Directions for the Breast Department
The aim is to build a modern specialty characterized by multidisciplinary collaboration and multi-professional integration, leveraging comprehensive technological advantages to boost market competitiveness and service capabilities.
Key initiatives include:
• Offering comprehensive treatment for all types of breast diseases—ranging from integrated Chinese and Western medicine approaches for non-tumorous conditions to minimally invasive treatments for benign tumors.
• Providing breast health care services, which encompass correction of developmental or deformative issues during puberty, promoting lactation and breast care during the perinatal period, supporting breastfeeding during lactation, and preventive care during weaning to avoid diseases and breast deformities.
• Implementing tumor rehabilitation management that covers postoperative functional recovery and rehabilitation for patients with gynecological tumors and breast cancer, psychological counseling, traditional Chinese medicine-based constitution adjustment, dietary and nutritional management, management of side effects from radiotherapy and chemotherapy, and facilitating the social reintegration of tumor patients.
VI. Comprehensive Benefits Analysis
Assuming reasonable equipment configuration, mastery of basic technologies, and effective promotion, the following benefits can be achieved:
-
Outpatient Examination Revenue
By implementing an effective integrated marketing strategy, we can increase the utilization rates of color ultrasound by 80%, X-ray examinations by 30%, and ductoscopy by 10%. Moreover, every patient requiring ductoscopy will also undergo tests for infectious diseases, complete blood counts, and coagulation function—thereby generating additional revenue from laboratory fees. -
Revenue from the Treatment of Benign Non-Tumorous Diseases
With standardized examinations, if the detection rate for non-tumorous conditions reaches 50%, approximately 495 positive cases could be identified monthly. Among these, around 70% would be mild cases, and about 50% of those patients would opt for outpatient treatment. Depending on the condition, treatment fees would range between RMB 3,000 and 5,000 per patient. -
Revenue from Breast Surgery (Minimally Invasive or Open Procedures)
Benign tumor patients are estimated to constitute 2%–3% of the outpatient population. -
Revenue from Treating Postpartum Lactation Disorders
This includes treatment for conditions such as postpartum milk stasis and insufficient milk production. -
Revenue from Breast Cancer Rehabilitation Management
National guidelines mandate chronic disease management for cancer patients, with each patient incurring an estimated annual comprehensive medical cost of RMB 15,000. The admission of postoperative breast cancer rehabilitation patients would therefore contribute to increased medical benefits.
VII. Construction Model
We propose leveraging external expertise by inviting a professional team with proven experience in establishing specialized disciplines. This team would provide comprehensive guidance in areas such as discipline planning, system development, talent cultivation, technical training, and operational management—thereby establishing a fully functional, well-structured, and highly effective specialty with significant benefits.
VIII. Supporting Equipment for the Breast Specialty Project
-
Breast Duct Endoscope (Examination and Treatment Equipment) – Quantity: 1
• Provides a solution to the challenge of indirect diagnosis of intraductal lesions by allowing direct visualization, thereby opening a new diagnostic pathway for the qualitative assessment of these lesions and enabling timely detection and treatment of early-stage tumors.
• Assists in tumor localization by reducing the surgical scope for most patients, modifying certain surgical indications for breast diseases, and helping some patients avoid unnecessary surgeries.
• Facilitates local drug delivery and duct clearance treatments for conditions such as plasma cell mastitis, milk stasis, and ductal dilatation, compensating for the limited efficacy of oral medications, and in some cases, eliminating the need for surgery.
• Allows for precise tissue biopsy under direct visualization to achieve an accurate diagnosis. -
Breast Treatment Device (Therapeutic Equipment) – Quantity: 3
• Primarily utilizes bionic massage and simulated acupressure techniques, applied to areas of breast lesions to eliminate tissue adhesions and relieve pain through transcutaneous electrical nerve stimulation (TENS).
• Also serves as a key component in “breast duct interventional lavage therapy,” which is essential for achieving therapeutic outcomes. Notably, over 80% of ductal carcinoma in situ originates from the breast ducts, and many benign diseases are directly linked to ductal blockage. -
Breast Traditional Chinese Medicine Vaporization Therapy Machine (Therapeutic Equipment) – Quantity: 3
• After vaporization, the active ingredients in Chinese herbal medicine exist as microparticles, which can more effectively penetrate the skin and enter breast tissue.
• When used concurrently with drug vaporization therapy, it significantly enhances the treatment effect. Based on modern medical diagnostics combined with traditional Chinese medicine syndrome differentiation and expert herbal formulations, the treatment becomes more targeted and effective, and it integrates seamlessly with subsequent therapies. -
Patient Source Management System (Patient Referral and Promotion) – Quantity: 1
• The system includes modules for managing a knowledge base on breast disease consultations, appointment scheduling, disease information, patient records, and expert resources.
• It facilitates scheduling for outpatient departments, individual doctors, treatments, and both initial and follow-up consultations, along with comprehensive schedule management. The system can automatically categorize and rank patients for targeted follow-up, prompt for return visits, and manage follow-ups through customizable conditions (such as appointment type, re-examination, disease category, patient attributes, birthdays, patient origin, and ranking), including the bulk dissemination of SMS or WeChat messages.
• It incorporates complaint management by recording and categorizing patient complaints.
• Additionally, the system performs automated media promotion analysis, including assessments of advertising effectiveness, regional patient demographics, and marketing strategies. -
Breast Department System Construction and Technical Training
• This encompasses the comprehensive development of the breast specialty system and the provision of technical training programs.
If there are no issues with the above report, please have the hospital leadership review and approve the project.